[{"NetIncomeLoss_1_Q2_USD":-80543.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q2_USD":2831809.0,"RepaymentsOfRelatedPartyDebt_2_Q2_USD":175000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":76007090.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":7600709.0,"AssetsCurrent_0_Q2_USD":933632.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":78231912.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-80090412.0,"CommitmentsAndContingencies_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"CommonStockSharesIssued_0_Q2_shares":2564582.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":175000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":783713.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":256690.0,"StockIssuedDuringPeriodSharesNewIssues_1_Q2_shares":8009041.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":81063721.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":80095253.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":256.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":20787.0,"Liabilities_0_Q2_USD":21787.0,"Assets_0_Q2_USD":81028885.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":78488602.0,"NetIncomeLoss_2_Q2_USD":-80623.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":151430.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"AdditionalPaidInCapital_0_Q2_USD":5081375.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":783713.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-214596.0,"CommonStockSharesOutstanding_0_Q2_shares":2564582.0,"DeferredTaxAssetsGross_0_Q2_USD":17000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":758713.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-81623.0,"StockholdersEquity_0_Q2_USD":5000008.0,"ProfitLoss_2_Q2_USD":-80623.0,"DeferredTaxAssetsValuationAllowance_0_Q2_USD":17000.0,"ProceedsFromIssuanceOfWarrants_2_Q2_USD":2831809.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":81028885.0,"PreferredStockValue_0_Q2_USD":null,"InvestmentIncomeInterest_1_Q2_USD":4841.0,"InvestmentIncomeInterest_2_Q2_USD":4841.0,"OperatingIncomeLoss_1_Q2_USD":-85384.0,"OperatingIncomeLoss_2_Q2_USD":-85464.0,"CommonStockSharesAuthorized_0_Q2_shares":30000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PrepaidExpenseCurrent_0_Q2_USD":149919.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":149919.0,"Ticker":"SNCE","CIK":"1819113","name":"LIFESCI ACQUISITION II CORP.","OfficialName":"Science 37 Holdings Inc. Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"516256808.0","Country":"United States","Sector":"Technology","Industry":"Computer Software: Prepackaged Software","Market":"NASDAQ","SP500":"nan","filed":"20210202"}]